This issue of the Journal concerns the reports of a recent symposium on hypertensive TOD. Besides oral presentations, a panel discussion was held where the practical implications for clini cians were discussed. In short, we want to sum marize here the conclusions of this discussion and the consequences for daily practice as related to the different kinds of organ damage.
Heart and coronary circulation
As stated above, there is no doubt that the presence of hypertensive TOD to the heart in creases the risk of cardiac morbidity and mortal ity. In particular, the demonstration of left ven 0300-2977/95/309.50 © 1995 also more quantitative informa tion than the ECG. Second, the echo can deliver other specific information e.g., about systolic and/or diastolic (dys)function. The latter is often disturbed before LVH is even apparent, espe cially in elderly subjects. Third, since echocardio graphy is just as patient-friendly as the ECG, it can be repeated during follow-up by which pro gression or regression of LVM and the improve ment or worsening of systolic and/or diastolic function can be followed. Are there then no disadvantages of echocardiography? Of course there are: for example, in 10-20% the imaging may be insufficient for calculating LVM. These problems are more prominent in obese subjects and, as known, most hypertensives are at least overweight. Other limitations are the time, costs and experience needed before accuracy becomes sufficient. Even then there remains considerable inter-and intra-doctor variation. To perform echocardiography in all hypertensive patients would mean that general physicians should send their patients at least once for echocardiography to their local cardiology departments. It is quite obvious that this would have wide implications in terms of financial costs and for the organization of this service.
What are the possible consequences of the echocardiographic findings? It may lead to better selection of hypertensives who are at greater risk, but it should be noted that prospective data are still lacking, especially for the early stages. A diagnosis of LVH may influence the individual cost-benefit balance: e.g., one will decide earlier for the addition of an extra drug, or an adverse reaction will be more easily accepted. Another potential consequence of the presence of LVH can be the choice of drug. Although in two often-cited reviews it is suggested that some classes of antihypertensive drugs are superior to others with regard to reversal of LVH, most of the studies used in the reviews were uncontrolled and/or not blinded. In this respect the paper by Fagard in this issue clearly shows that if a meta analysis is performed with controlled studies only, no particular class of antihypertensives has the exclusive property of LVH reduction.
There are some other important aspects of the relation between hypertension and the heart: e.g., the diminished coronary flow reserve or the pres ence of subclinical myocardial ischaemia. Al though both topics are interesting in terms of research as shown in the article by Magrini and colleagues in this issue, there have been no direct consequences so far for everyday practice,
Cerebral and peripheral circulation
After cardiac events, cerebrovascular events come second in frequency. Therefore, research on the cerebral circulation in hypertension was started long ago. The review by Strangaard and Paulson in this issue gives an actual impression by the most experienced investigators in this field. However, their method of measuring cerebral blood flow cannot be used in large-scale studies. A number of new non-invasive techniques for this purpose are now being developed: newer CTscans, MRI or MR-angiography, and near-in frared spectroscopy (NIRS) etc. A development already more close to clinical practice is that developed by and described in this issue by Reneman and Hoeks. It has been developed for the study of the distensibility and compliance of the carotid artery, e.g. in hypertension. Interesting observations demonstrate differences between different drugs with regard to the properties of the carotid artery wall, but no studies with objec tive end-points are presently available. Though promising for clinical and fundamental research in specialized centres, the method is not available for general daily practice. 
Renal organ damage due to hypertension
The kidney can be the cause of hypertension but also the target for damage by hypertension. The improvement of antihypertensive treatment protects patients from dying from major cerebral and cardiac events. Thus an increasing number of elderly subjects remain at risk for damage in other target organs, e.g. the kidney. The ever increasing life expectancy in most western coun tries is an additive factor. These factors explain that over the last decennium the percentage of patients coming to dialysis after longstanding pri mary hypertension has risen. Most clinicians will follow the course of the kidney function and eventual proteinuria at regular intervals in their hypertensive patients, but once these parameters deteriorate we are too late. In diabetic patients the determination of microalbuminuria is an early sign of renal damage. For hypertension, with its slower deterioration of kidney function, there are no data so far that demonstrate that regular nephelometric determination of urinary albumin excretion has any prognostic value. There may be a subgroup where there are indeed arguments that it is a cost-effective diagnostic procedure. Generally speaking, no strong advice can be given at present as to whether or not it is useful to determine microalbuminuria. Some studies are currently underway. The paper by de Leeuw and Birkenhâger in this issue gives the pathophysio logical background and also discusses the influ ence of antihypertensive drugs both as a cause of renal function disturbances and as therapy for renal damage.
Hypertensive retinal damage
The retina is the place where atherosclerosis can be observed and followed easily with (almost) non-invasive methods. Although the significance of fundoscopy for accelerated or malignant hy pertension is beyond doubt, the use of retinal inspection in subjects who have no malignant or accelerated hypertension is questionable. Several practical difficulties limit the wide-scale applica tion of retinoscopy in all hypertensive subjects: it costs time, experience is needed, the more quali tative rather than quantitative scoring and the disadvantage of mydriasis for the outclinic pa tient. Recently there have been some develop ments with alternative methods measuring retinal atherosclerosis and remodelling in hypertension and/or diabetes using standardized retinal pho tographs.
Conclusions for the clinician
The heart, kidney and cerebral blood vessels are still the major target organs for damage by hypertension. The assessment and follow-up of TOD of these organs should be improved. It seems that detection of subgroups of patients with only mild hypertension but with subclinical or early TOD would be beneficial. More vigorous treatment of these subjects might improve the clinical outcome in the long term. However, prospective studies in this area of extension of diagnostic procedures and treatment intensifica tion are mandatory in order to justify the unevitable increments in side-effects and financial costs. At present, for the clinician measurement of renal function and protein excretion and the 
